Advertent Biotherapeutics, Inc.
Publicly observedEast Lansing, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | East Lansing | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Advertent Biotherapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JYQ5STUGHCA9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jul 2025Publicly observed
NIH SBIR/STTR award: A novel agent for preventing fatty degeneration of muscles in LGMD2B
USD 750,221.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2025Publicly observed
NIH SBIR/STTR award: A novel agent for preventing fatty degeneration of muscles in LGMD2B
USD 1,292,847.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.